CEO update December 2019

18-Dec-2019

Sienna Cancer Diagnostics Limited (ASX:SDX) Managing Director and CEO Carl Stubbings talks about the company's capital raising and co-development of tests using its SIEN-NET liquid biopsies platform technology.



The interview can also be accessed here: https://www.finnewsnetwork.com.au/MediaCenter/MediaCenterMobile.aspx?Site=FNN1722



 
Comment

No Very




Captcha Image

Sign up for updates